Descripción

Dectova (Zanamivir IV) – Antiviral for Severe Influenza (Rx)

Dectova contains zanamivir, a neuraminidase inhibitor antiviral used for the treatment of complicated and potentially life-threatening influenza infections in adults and children (from 6 months of age). It is specifically indicated for patients who are hospitalized or when other antiviral options (such as oral or inhaled treatments) are not suitable or ineffective.

buy Dectova without prescription

We sell over-the-counter Dectova medicine; buy medicines with no prescription
entrega rápida, discreta y confiable
pago rápido y seguro
Comprar discretamente sin dejar rastro

Zanamivir works by inhibiting the viral neuraminidase enzyme, preventing the release of new influenza virus particles from infected cells. This limits viral spread within the respiratory tract and helps reduce disease severity and progression.

Key Details

• Active Ingredient: Zanamivir
• Brand Name: Dectova
• Drug Class: Neuraminidase inhibitor (antiviral)
• Indication: Severe or complicated influenza infection
• Route: Intravenous (IV) infusion
• Use Setting: Primarily hospital-based treatment
• Prescription Status: Prescription-only medicine

Especificaciones

• Dosage Form: Powder for concentrate for solution for infusion
• Administration: Intravenous infusion (after reconstitution and dilution)
• Dosing Frequency: Typically twice daily (adjusted by weight, age, renal function)
• Onset of Action: Rapid systemic antiviral activity after IV administration
• Half-Life: ~2.5–3 hours
• Metabolism: Minimal metabolism
• Excretion: Primarily renal (unchanged drug)
• Storage: Store vials below 25°C; protect from light

Dosage & Administration

• Dose is individualized based on patient weight, age, and renal function
• Common adult dosing: 600 mg IV twice daily (adjusted as needed)
• Treatment duration typically 5–10 days, depending on severity
• Requires clinical monitoring in hospital settings

Compatibility / Suitable Use

• Patients with severe or complicated influenza
• Individuals unable to take oral or inhaled antivirals
• Hospitalized patients, including those in intensive care
• Suitable for pediatric and adult patients (per guidelines)
• Requires specialist medical supervision

Why Choose Dectova?

Dectova provides a critical IV antiviral option for managing severe influenza infections, especially when standard oral or inhaled therapies are not viable. Its targeted antiviral mechanism and hospital-based administration make it essential in critical care and infectious disease management.